Tayek, J. A., Stolz, A. A., Nguyen, D. V., Fleischman, M. W., Donovan, J. A., Alcorn, J. M., Chao, D. C., Asghar, A., Morgan, T. R., , , Birudaraju, D., Botwin, G., Buddha, H., Cherukuri, L., Cruz, S., French, M., Gonzalez, R., Gozum, J., Gutierrez, R., Hamal, S., Head, P., Jones, C., Kaplowitz, N., Lee, R., MacHarg, L., Milstein, S., Ouyang, Y., Rico, C., & Zarick, C. (2022). a phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. EClinicalMedicine, 54, . http://access.bl.uk/ark:/81055/vdc_100172522824.0x000001